Olanzapine (5 mg) plus standard triple antiemetic therapy for the prevention of multiple-day cisplatin hemotherapy-induced nausea and vomiting: a prospective randomized controlled study

OBJECTIVE: A prospective randomized controlled trial was conducted to compare 5 mg olanzapine plus standard triple antiemetic therapy for the prevention of nausea and vomiting induced by multiple-day cisplatin chemotherapy. METHODS: Patients who received a 3-day cisplatin-based chemotherapy (25 mg/m...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jiali, Zhao, Jun, Jiang, Caihong, Chen, Feng, Zhao, Lanzhen, Jiang, Ying, Li, Hui, Wang, Wenjuan, Wu, Yungaowa, Jin, Yilan, Da, Lenggaowa, Liu, Guang, Zhang, Yajuan, Li, Hongxia, Zhang, Zewei, Jin, Gaowa, Li, Quanfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135873/
https://www.ncbi.nlm.nih.gov/pubmed/35449368
http://dx.doi.org/10.1007/s00520-022-07067-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135873/
https://www.ncbi.nlm.nih.gov/pubmed/35449368
http://dx.doi.org/10.1007/s00520-022-07067-6

Ejemplares similares